title: Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease.
authors.forename: Gang
authors.initials: G
authors.lastname: Cheng
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Kwee
authors.forename: Sandip
authors.initials: S
authors.lastname: Basu
authors.forename: Abass
authors.initials: A
authors.lastname: Alavi
mesh_terms: D001859:Bone Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D004338:Drug Combinations; D005462:Fluorine Radioisotopes / Q000008:administration & dosage; D019788:Fluorodeoxyglucose F18 / Q000008:administration & dosage; D006801:Humans; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18